Science ❯ Biotechnology

Genomics

DNA Sequencing Gene Editing Synthetic Biology Pathogen Surveillance Next-Generation Sequencing Plant Science Whole Genome Sequencing Cancer Genomics RNA Sequencing Cancer Research Transcriptomics Genetic Variation Metagenomics mRNA Technology Neoantigens Phenotyping Research and Development Microbial Genomics Gene Therapy Drug Development Sequencing Technology Clinical Genomics DNA Repair Mechanisms Breeding Technologies Agricultural Science Crop Development Single-Cell Sequencing Gene Expression Research Institutions Genome Editing Drug Discovery Conservation Technology Insect Behavior Medical Applications Single Cell Analysis Craig J. Venter DNA Research Crop Improvement DNA Methylation Clinical Research RNA Biology Integrative Biology AI Applications Proteomics Biodiversity Personalized Medicine Companies Clinical Data Data Analysis Health Informatics Human DNA Mapping

Tempus Shares Reprice After Merck–Moderna Phase 3 Win Boosts Value of Sequencing Business

The vaccine readout raises the commercial importance of tumor sequencing and diagnostic platforms, potentially speeding commercialization and regulatory talks for personalized cancer therapies.

Tempus AI Agrees to Buy Personalis for $1.5 Billion

CIPHER-seq Maps RNA-to-Protein Timing in Single Immune Cells

Merck and Mayo Clinic Launch AI Drug Discovery Collaboration Using Platform_Orchestrate

Illumina Launches Billion Cell Atlas to Train AI in Drug Discovery

Colossal Foundation Hits $100 Million to Scale Biotech Conservation

EU Strikes Provisional Deal to Ease Rules for Gene-Edited Crops

Prime Editing Tool PERT Debuts as Broad, One-Time Strategy for Nonsense Mutations

Long-Read Sequencing and 'LongTrack' Map Donor Bacteria After Fecal Transplants

AI Model MSI-SEER Validated Across Diverse Cancer Cohorts and Prepares for Prospective Trials

New Study Highlights mNGS's Breakthrough in Diagnosing Lung Infections